NOAH Compendium

Printed from NOAH Compendium (https://www.noahcompendium.co.uk). (c) Copyright NOAH Compendium 2024. All Rights Reserved.
Date: Saturday, May 18, 2024 12:02

Release 3.58
Poulvac MD-Vac lyophilisate and diluent for suspension for injection
 
Species: Chickens
Therapeutic indication: Immunological veterinary medical products: For poultry
Active ingredient: Vaccine Antigens
Product:Poulvac® MD-Vac lyophilisate and diluent for suspension for injection
Product index: Poulvac MD-Vac
Poultry - meat: Zero days
Poultry - eggs: Zero days
Incorporating:
Presentation
Lyophilisate and diluent for suspension for injection.
Marek HVT strain F#126 2,250-17,500 PFU per 0.2ml dose.
Uses
To prevent mortality and clinical signs due to infection with Marek's disease virus. Onset of immunity has been demonstrated from 5 days after vaccination. No information is available on the duration of the protection elicited by vaccination. However, experience in the field suggests that Marek's disease vaccine virus strains and antibody titres persist for up to 2 years after vaccination.
Dosage and administration
One dose of 0.2ml per chicken.
The vaccine is to be administered either by intramuscular injection in the thigh or by subcutaneous injection in the neck to one-day-old chickens.
Reconstitute each 1,000 doses of Poulvac MD Vac with 200 ml of diluent at room temperature. Remove the centre tabs of aluminium seals on both vaccine vial and diluent bottle, leaving intact the outer ring on both vial and bottle. Cleanse rubber stoppers with alcohol and allow to dry. All equipment used for vaccination should be sterile and contain no traces of detergents or disinfectants. Using a sterile needle and syringe, insert through diluent bottle stopper and withdraw 3 ml of diluent. Transfer by inserting through vaccine vial stopper. After slight agitation of the vial to ensure that the vaccine has dissolved, insert needle and withdraw entire contents into the syringe. Remove the syringe containing all the reconstituted vaccine from vial and re-insert into diluent bottle. Expel syringe contents into diluent. The reconstituted vaccine is now ready for use. For administration of the vaccine an automatic syringe with a 23 gauge x 1 inch (0.60 x 25 mm) needle is recommended. Inject each chick intramuscularly with 0.2 ml of vaccine, the usual site being the upper thigh, or subcutaneously in the neck. Use within 2 hours of reconstitution.
Advice on correct administration
Avoid exposure to heat or direct sunlight. Avoid contact with disinfectants as this renders the vaccine inactive. Use clean materials for vaccination. Avoid stress in chickens before and after vaccination. Avoid injection into or near joints and tendons.
Contra-indications, warnings, etc
For Animal Treatment Only.
Do not use in sick chickens. Do not vaccinate in an infected environment. Do not use in birds in lay. Safety and efficacy data are available which demonstrate that this vaccine can be administered on the same day but not mixed with Poulvac IBMM, Poulvac Hitchner B1 and Poulvac Bursine 2. The products should be given at different sites. No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product except the products mentioned above. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis. Do not mix with any other veterinary medicinal product except the diluent supplied.
Maternally-derived antibody (MDA) can interfere with the development of active immunity. Where it is likely that recent field infection or vaccination of the parent flock has stimulated a high antibody titre and consequently a high level of MDA, the timing of the vaccination programme should be planned accordingly.
Adverse Reactions
No local or systemic reactions have been observed following the administration of the vaccine during safety studies. However, and in common with other immunological products, it is expected that local or systemic reactions may occur in a very small proportion of vaccinated birds.
Withdrawal period
Zero days
Pharmaceutical precautions
Keep out of the reach and sight of children.
Poulvac MD Vac
Store and transport at +2°C to +8°C. Do not freeze. Protect from light.
Poulvac Marek Diluent
Store and transport at room temperature or at +2°C to +8°C in the dark. Avoid exposure to heat and/or direct sunlight. Do not freeze.
Following dilution the dissolved vaccine should be kept at room temperature and used within 2 hours.
Legal category
Legal category: POM-VPS
Packaging quantities
Poulvac MD Vac
10 x 500, 1000 and 2000 dose.
Poulvac Marek Diluent
Glass bottles of 200 ml, 400 ml or 500 ml.
Collapsible plastic bag of 200 ml, 400 ml, 500 ml, 600 ml, 800 ml or 1 litre.
Not all pack sizes may be marketed.
Further information
No local or systemic reactions have been observed after the administration of a tenfold overdose.
Disposal:
Dispose of waste material by boiling, incineration or immersion in an appropriate disinfectant approved for use by the competent authorities.
Marketing Authorisation Number
Vm 42058/4109
Significant changes
GTIN
GTIN description:10 x 1000 dose:
GTIN:08714015011792